Treatment of cutaneous leishmaniasis patients with pentostam via intralesion infiltration.
Cutaneous leishmaniasis (CL) is an endemic disease in Egypt. Systematic treatment with pentostam has its disadvantages and contraindications. In this study, six out of eight parasitologically proved CL patients recovered with intralesion infiltration with a dose of pentostam ranged between 0.8 to 1.6 gm. The other 2 patients did not show response with a dose up to 2 gm. The results were discussed.